Skip to main content
article atm-icon bar bell bio cancel-o cancel ch-icon crisis-color crisis cs-icon doc-icon down-angle down-arrow-o down-triangle download email-small email external facebook googleplus hamburger image-icon info-o info instagram left-angle-o left-angle left-arrow-2 left-arrow linkedin loader menu minus-o pdf-icon pencil photography pinterest play-icon plus-o press right-angle-o right-angle right-arrow-o right-arrow right-diag-arrow rss search tags time twitter up-arrow-o videos

Suggested Content


Grifols is a global healthcare company with a mission to improve the health and well being of people around the world. Headquartered in Barcelona, Spain, and with offices in North Carolina, Grifols is a leading producer of plasma medicines for the treatment of rare, chronic, and life-threatening conditions.

Since 2010, Grifols has partnered with Americares, with the total value of donations reaching $4.8 million. The donations received from Grifols have been sent to 6 countries: Armenia, Eritrea, Paraguay, Romania, Senegal, and Tanzania.

Grifols partners with Americares heavily for hemophilia drugs and medications. In late-August 2013, Grifols donated most of the therapies needed for Camp Ray of Hope in North Carolina to host 40 children from Romania who suffer from hemophilia. The camp gives children with hemophilia the opportunity to engage in physical activities that are too dangerous the rest of the year.

Hemophilia is a rare, genetic disorder primarily affecting boys that prevents blood from clotting. Children with hemophilia risk serious, and sometimes life-threatening injuries from even a minor cut or fall. While there is no cure for the disease, hemophilia can be managed through regular administration of blood-clotting medications, Factor VII and Factor IX.